Canton Hathaway LLC Sells 150 Shares of Danaher Co. (NYSE:DHR)

Canton Hathaway LLC reduced its position in shares of Danaher Co. (NYSE:DHR) by 1.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,575 shares of the conglomerate’s stock after selling 150 shares during the quarter. Danaher comprises about 0.7% of Canton Hathaway LLC’s portfolio, making the stock its 24th biggest position. Canton Hathaway LLC’s holdings in Danaher were worth $2,657,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher in the 4th quarter worth $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher in the 4th quarter valued at about $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher in the 4th quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America bought a new position in shares of Danaher in the third quarter valued at approximately $39,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in shares of Danaher during the third quarter valued at approximately $40,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 0.5 %

NYSE:DHR opened at $211.23 on Tuesday. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70. The company has a market capitalization of $150.97 billion, a PE ratio of 40.01, a P/E/G ratio of 2.66 and a beta of 0.83. The firm’s 50-day moving average price is $226.25 and its 200-day moving average price is $246.44. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the business earned $2.09 earnings per share. On average, equities analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.61%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is 24.24%.

Analyst Ratings Changes

DHR has been the subject of several research analyst reports. Jefferies Financial Group decreased their target price on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Barclays cut their target price on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Wells Fargo & Company decreased their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Finally, Robert W. Baird lowered their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.